Resultats globals: 2 registres trobats en 0.01 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
11 p, 679.0 KB Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved? / Jarrin, Inma (Instituto de Salud Carlos III, Madrid, Spain) ; Pantazis, Nikos (Athens University Medical School, Athens, Greece) ; Dalmau, Judith (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Phillips, Andrew N. (Research Department of Infection and Population Health) ; Olson, Ashley (Medical Research Council Clinical Trials Unit, University College London, London, UK) ; Mussini, Cristina (Institute of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy) ; Boufassa, Faroudy (Univ Paris-Sud, Le Kremlim Bicetre) ; Costagliola, Dominique (INSERM, Paris, France) ; Porter, Kholoud (Medical Research Council Clinical Trials Unit, University College London, London, UK) ; Blanco, Juliá (Universitat de Vic-Central de Catalunya, UVIC-UCC, Vic) ; Del Amo, Julia (Instituto de Salud Carlos III, Madrid, Spain) ; Martínez Picado, Francisco Javier (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
This article compares trends in CD4 + T-cell recovery and proportions achieving optimal restoration (≥500 cells/μl) after viral suppression following combination antiretroviral therapy (cART) initiation between rapid and nonrapid progressors. [...]
2015 - 10.1097/QAD.0000000000000805
AIDS (London, England), Vol. 29 (october 2015) , p. 2323-2333  
2.
7 p, 215.9 KB Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype / Olson, Ashley D. (University College London. Medical Research Council Clinical Trials Unit (United Kingdom)) ; Guiguet, Marguerite (Université Pierre et Marie Curie (France)) ; Zangerle, Robert (Innsbruck Medical University (Austria)) ; Gill, John (University of Calgary (Canada)) ; Perez-Hoyos, Santiago (Vall d'Hebrón Institut de Recerca (VHIR)) ; Lodi, Sara (Instituto de Salud Carlos III) ; Ghosn, Jade (CHU Bicêtre. Service de Médecine Interne et Maladies Infectieuses (France)) ; Dorrucci, Maria (Istituto Superiore di Sanità (Italy)) ; Johnson, Anne (University College London. Institute of Epidemiology and Health Care (United Kingdom)) ; Sannes, Mette (Ulleval University Hospital (Norway)) ; Moreno, Santiago (Hospital Universitario Ramón y Cajal) ; Porter, Kholoud (University College London. Medical Research Council Clinical Trials Unit (United Kingdom)) ; Universitat Autònoma de Barcelona
Supplemental Digital Content is Available in the Text. Rapid CD4 cell loss represents an HIV phenotype used to identify causal variants of accelerated disease progression. The optimal rate and threshold for identifying this extreme phenotype in recently infected individuals is unclear. [...]
2014 - 10.1097/QAI.0000000000000240
Journal of acquired immune deficiency syndromes (1999), Vol. 67, Issue 1 (September 2014) , p. 15-21  

Vegeu també: autors amb noms similars
2 Olson, Ashley D.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.